Ironwood Study Chair
Ironwood Pharmaceuticals · Ironwood Pharmaceuticals, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ironwood Study Chair as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:16 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05362695 · A Study of Multiple-ascending Doses of IW-3300 in Healthy SubjectsIronwood Pharmaceuticals, Inc. · completed · Healthy Volunteers · study director
- Ph1NCT05188261 · A Study of Single Ascending Doses of IW-3300 in Healthy VolunteersIronwood Pharmaceuticals, Inc. · completed · Healthy Volunteers · study director
- Ph4NCT03226899 · A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal ImpairmentIronwood Pharmaceuticals, Inc. · terminated · Gout, Chronic Kidney Disease (CKD) · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.